Zymergi LogoCart

483 Document: Aurobindo Pharma Limited, Nov 18, 2022

FDANews 483 Aurobindo Pharma Limited Nov 18 2022 top
Lata C. Mathew FDA Investigator Arsen Karapetyan FDA Investigator

On Nov 18, 2022, the FDA inspected Aurobindo Pharma Limited's Doultabad site. Explore the inspectional observations.